A new study has found that reduced dopamine activity in the brain may play a significant role in memory impairment, adding a fresh dimension to understanding Alzheimer’s disease beyond the long-studied amyloid and tau protein build-up.

Researchers from Tohoku University and the University of California, Irvine report that dysfunction in the brain’s dopamine system could be an overlooked contributor to cognitive decline. The findings were published in the journal Nature Neuroscience.

For decades, most Alzheimer’s research has focused on amyloid-beta plaques and tau tangles in the brain. However, treatments targeting these factors have shown limited success in restoring memory, prompting scientists to explore additional biological pathways involved in the disease.

The study suggests that disruptions in dopamine signaling may significantly affect memory formation and cognitive performance in patients. Researchers say restoring dopamine activity could open a potential new therapeutic direction for treating memory-related disorders, including Alzheimer’s disease.

While the findings offer a new perspective on brain function and neurodegeneration, scientists emphasize that further clinical research is needed to determine whether dopamine-based interventions can translate into effective treatments.

Also Read : Study links faster biological ageing among younger adults to rising cancer risk